CTXR vs XPEV · rev $7.1M vs rev $895.7M
Citius Pharmaceuticals Inc (CTXR) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
CTXR currently screens at market cap $13.4M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the CTXR and XPEV stock pages for the full models.
Not investment advice.